Colgate-Palmolive (CL) Scheduled to Post Earnings on Friday

Colgate-Palmolive (NYSE:CL) is scheduled to be announcing its earnings results before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of $0.82 per share for the quarter. Colgate-Palmolive has set its FY 2024 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same quarter last year, the business earned $0.77 earnings per share. Colgate-Palmolive’s revenue was up 6.9% compared to the same quarter last year. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $88.58 on Wednesday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $90.37. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The firm has a market capitalization of $72.81 billion, a price-to-earnings ratio of 31.86, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42. The business has a 50 day simple moving average of $87.29 and a 200 day simple moving average of $81.20.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.26%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is 71.94%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock valued at $19,505,099 in the last quarter. Corporate insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

CL has been the subject of several research analyst reports. UBS Group upped their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. The Goldman Sachs Group initiated coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. Finally, Wells Fargo & Company increased their price objective on Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $89.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.